Trial intelligence / Profile preview

SonoVue Guided vs Systematic Prostate Biopsy

NCT00911027Phase 3Terminated

Sponsor
Bracco Diagnostics Inc.
Start
Feb 2009
Primary completion
Mar 2011
Modality
Small Molecules
Countries
7
01

Overview

A Phase 3 trial of sulfur hexafluoride in prostate cancer (PCa), sponsored by Bracco Diagnostics Inc.. Started Feb 2009; status: terminated.

02

Drugs

sulfur hexafluoride
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00911027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00911027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call